Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Zalicus, Inc.
Pharmaceutical Preparations MA, United States
Nasdaq: ZLCS
Company Description
Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The company has a portfolio of clinical-stage product candidates targeting pain and immuno-inflammatory diseases. It has two subsidiaries: Zalicus Pharmaceuticals Ltd. and Zalicus Securities Corp. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
Similar to: United-Guardian, Inc., ViroPharma, Inc., Trius Therapeutics, Inc.
Featured Company
BillerudKorsnäs
Solna, SE
BillerudKorsnäs offers primary fibre-based packaging material and packaging solutions. The company has a prominent position within… Learn more →
Social Monitor
You may also be interested in:
Trius Therapeutics, Inc.
San Diego, CA, US
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics… Learn more →
ViroPharma, Inc.
Exton, PA, US
ViroPharma is rare among biotechnology companies. We are in the enviable position of having a strong and growing balance sheet; a… Learn more →
United-Guardian, Inc.
Hauppauge, NY, US
United-Guardian, Inc. engages in the research, development, manufacture, and marketing of cosmetic ingredients, personal and health… Learn more →